United States
Germany
Japan
United Kingdom
China
Anti-MAPK1 (ERK2) mouse monoclonal antibody, clone OTI6F8 (formerly 6F8)
| Applications | FC, IHC, IP, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
Antibodies
RPA2 mouse monoclonal antibody, clone OTI7C12 (formerly 7C12)
| Applications | FC, IF, IHC, IP, WB |
| Reactivities | Human, Monkey, Mouse, Rat, Dog |
CNY 1,999.00
CNY 2,700.00
现货
Anti-LTA4H (Leukotriene A4 hydrolase) mouse monoclonal antibody, clone OTI8F4 (formerly 8F4)
| Applications | IF, IHC, IP, WB |
| Reactivities | Human, Dog, Rat, Mouse |
Anti-MAPK1 (ERK2) mouse monoclonal antibody, clone OTI4C2 (formerly 4C2)
| Applications | IF, IHC, IP, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
DAPK2 (DAP Kinase 2 ) mouse monoclonal antibody, clone OTI1C5 (formerly 1C5)
| Applications | FC, IF, IHC, IP, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
Anti-MAPK1 (ERK2) mouse monoclonal antibody, clone OTI6F8 (formerly 6F8)
| Applications | FC, IHC, IP, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
Anti-MAPK1 (ERK2) mouse monoclonal antibody, clone OTI4C2 (formerly 4C2)
| Applications | IF, IHC, IP, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
CNY 800.00
现货
Anti-LTA4H (Leukotriene A4 hydrolase) mouse monoclonal antibody, clone OTI8F4 (formerly 8F4)
| Applications | IF, IHC, IP, WB |
| Reactivities | Human, Dog, Rat, Mouse |
Anti-PLK1 mouse monoclonal antibody, clone OTI8C12 (formerly 8C12)
| Applications | FC, IF, IP, WB |
| Reactivities | Human, Dog, Monkey, Mouse, Rat |
活动过滤器
clear Category
-
Antibodies
- Primary Antibodies
优化搜索结果
Target Symbol
Knockout (KO) Validation
Brands
Pathways
- Bladder cancer (5)
- Oocyte meiosis (5)
- Pathways in cancer (5)
- Progesterone-mediated oocyte maturation (5)
- Acute myeloid leukemia (4)
- Adherens junction (4)
- Alzheimer's disease (4)
- Axon guidance (4)
- B cell receptor signaling pathway (4)
- Chemokine signaling pathway (4)
- Chronic myeloid leukemia (4)
- Colorectal cancer (4)
- Dorso-ventral axis formation (4)
- Endometrial cancer (4)
- ErbB signaling pathway (4)
- Fc epsilon RI signaling pathway (4)
- Fc gamma R-mediated phagocytosis (4)
- Focal adhesion (4)
- Gap junction (4)
- Glioma (4)
- GnRH signaling pathway (4)
- Insulin signaling pathway (4)
- Long-term depression (4)
- Long-term potentiation (4)
- MAPK signaling pathway (4)
- Melanogenesis (4)
- Melanoma (4)
- NOD-like receptor signaling pathway (4)
- Natural killer cell mediated cytotoxicity (4)
- Neurotrophin signaling pathway (4)
- Non-small cell lung cancer (4)
- Pancreatic cancer (4)
- Prion diseases (4)
- Prostate cancer (4)
- Regulation of actin cytoskeleton (4)
- Renal cell carcinoma (4)
- T cell receptor signaling pathway (4)
- TGF-beta signaling pathway (4)
- Thyroid cancer (4)
- Toll-like receptor signaling pathway (4)
- Type II diabetes mellitus (4)
- VEGF signaling pathway (4)
- Vascular smooth muscle contraction (4)
- mTOR signaling pathway (4)
- Arachidonic acid metabolism (2)
- Metabolic pathways (2)
- Cell cycle (1)
- DNA replication (1)
- Homologous recombination (1)
- Mismatch repair (1)
- Nucleotide excision repair (1)
